Glissandra™ Skincare Inc. today announced the global launch of its three signature anti-aging products concurrent with the Israel Cancer Research Fund’s “Women of Action” awards luncheon honoring Beverly Cohen, Lisi Harrison, and Vivien Zighelboim, Ph.D, at the Four Seasons Hotel, Los Angeles at Beverly Hills.
Glissandra donated the 3-Step Anti-Aging Skincare System to attendees in recognition of the Israel Cancer Research Fund’s own impressive dedication to research. The Glissandra Anti-Aging Skincare line includes restorative Serum,™ age-renewal Face Cream,™ and rejuvenating Eye Cream.™
The new skincare regimen is believed to be a first of breed formulation that marries science with the gifts of nature’s Schisandra berry to reverse and prevent the visible signs of aging by targeting its major causes, including mitochondrial decay. The products are recommended for all skin types, including those with eczema, dryness, and acne.
Glissandra’s unique ingredient Glissandrin,™
New Jersey-based branding and marketing agency Trajectory LLC (www.trajectory4brands.com)
About Glissandra™ Skincare Inc.
Glissandra™ Skincare Inc. is a privately owned skincare company based in Vancouver, Canada. The Glissandra™ 3-Step Skincare System is the result of more than 17 years of research and development at the internationally recognized Hong Kong University of Science and Technology by lead researcher Dr. Robert Ko, Professor of Biochemistry. Glissandra developed a proprietary process for extracting the Schisandrin compounds from the raw berry, refining while preserving the natural state for optimal potency. Glissandra is the first anti-aging bioceutical patented with the key Schisandra berry formulation proven to effectively combat the visible signs of aging and promote the healthy appearance of the skin by targeting mitochondrial decay. The key proprietary ingredient in Glissandra is Glissandrin™
About The Israel Cancer Research Fund
Israel Cancer Research Fund continues to be the largest source of private funds for cancer research in Israel. It is the only voluntary charitable organization in North America solely devoted to supporting innovative cancer research in Israel. ICRF has contributed over $40 million to underwrite approximately 2000 research grants involving all major hospitals, universities and cancer research institutions throughout Israel. ICRF has chapters in Los Angeles, Chicago, NY, Montreal, Toronto, and Israel. www.icrfla.org



